InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,459.10
(
1.11%
)
US TECH 100
18,522.40
(
1.05%
)
Dow Jones
40,589.34
(
1.64%
)
Brent Oil
79.75
(
0.00%
)
Bitcoin
67,899.30
(
-0.02%
)
Post# of 252696
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

ciotera

Send PM Follow Ignore
Followers 8
Posts 511
Boards Moderated 0
Alias Born 08/03/2005

ciotera

Re: DewDiligence post# 241169

Wednesday, 01/12/2022 5:09:47 PM

Wednesday, January 12, 2022 5:09:47 PM

Post# of 252696
Re: ABBV

They are great at execution in immunology, but I think that can only take you so far given the headwinds and intensifying competition. This is one of those "two turkeys don't make an eagle" situations. Even in the best case (which we are definitely no longer in, as far as the JAKs are concerned), replacing HUMIRA revenue across all of its indications (while competing with it) would be a very tall order.
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up